Showing results (491-500 of 1,009) with videos related to
Sort By:
Pageof 101
Health Equity|January 5, 2026
Using Stakeholder Engagement to Build Cancer Survivorship Care Coordination Capacity Between Primary and Oncology CareJulie S Armin, Sarah N Price, Elizabeth S Ver Hoeve, et al.Lancet (London, England)|March 6, 2007
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparisonA Ratcliff, H Siswantoro, E Kenangalem, et al.Plos One|July 30, 2013
Nonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparumJulie A Simpson, Kris M Jamsen, Tim J C Anderson, et al.Antimicrobial Agents and Chemotherapy|August 29, 2018
Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical ModelingSaber Dini, Sophie Zaloumis, Pengxing Cao, et al.Nature Communications|October 7, 2022
Covalent bond shortening and distortion induced by pressurization of thorium, uranium, and neptunium tetrakis aryloxidesJacob J Shephard, Victoria E J Berryman, Tatsumi Ochiai, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2009
Vivax malaria: a major cause of morbidity in early infancyJeanne R Poespoprodjo, Wendelina Fobia, Enny Kenangalem, et al.Biorxiv : the Preprint Server for Biology|April 3, 2026
The WalRK two-component system in Streptococcus pneumoniae ensures robustness of secondary wall polymer attachmentJustin J Zik, Zeyu Fu, Morgan N Price, et al.Plos Pathogens|March 13, 2015
Impaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activationTsin W Yeo, Daniel A Lampah, Enny Kenangalem, et al.Immunotherapy|January 10, 2024
Patterns of neurological adverse events among a retrospective cohort of patients receiving immune checkpoint inhibitorsJohn C Hunting, Andrew T Faucheux, Sarah N Price, et al.Scientific Reports|October 13, 2018
Integrated and efficient diffusion-relaxometry using ZEBRAJana Hutter, Paddy J Slator, Daan Christiaens, et al.Pageof 101